Ascletis Pharma Market Cap

Ascletis Pharma has a market cap or net worth of 17.70 billion as of April 29, 2026. Its market cap has increased by 140.17% in one year.

Market Cap

17.70B

Enterprise Value

15.59B

Revenue

2.26M

Ranking

n/a

PE Ratio

n/a

Stock Price

16.51

Market Cap Chart

Since August 1, 2018, Ascletis Pharma's market cap has increased from 15.69B to 17.70B, an increase of 12.81%. That is a compound annual growth rate of 1.57%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	17.70B	57.46%
Dec 31, 2025	11.24B	287.10%
Dec 31, 2024	2.90B	90.74%
Dec 29, 2023	1.52B	-70.46%
Dec 30, 2022	5.15B	44.13%
Dec 31, 2021	3.58B	13.38%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zai Lab	20.04B
Keymed Biosciences	22.39B
TransThera Sciences (Nanjing)	23.68B
Ascentage Pharma Group International	17.22B
Nanjing Leads Biolabs	16.48B
Shanghai Bao Pharmaceuticals	25.38B
Duality Biotherapeutics	26.43B
CStone Pharmaceuticals	15.46B

Market Cap Rankings